The ongoing lawsuits over allegedly carcinogenic talcum powder products have put Johnson under pressure.
A US federal judge has refused to resolve the matter via insolvency proceedings.
The financial risk at Johnson is high, new uncertainty in the strategic direction.
Johnson the new Bayer $BAYN (+0,56 %) and 3M $MMM (+1,75 %) ?
Bottomless pit, the share has been in a volatile downward trend since 2022. Once again, the upper boundary line was not broken.
